Skip to main content
The Egyptian Journal of Bronchology
Download PDF
  • Original article
  • Open access
  • Published:

Differentiation between pneumocystis jirovecii pneumonia and colonization in immunocompromised patients

Egyptian Journal of Bronchology volume 12, pages 467–472 (2018)Cite this article

Abstract

Background

The diagnosis of Pneumocystis jirovecii pneumonia (PJP) is mainly based on microscopic detection of P. jirovecii in the respiratory samples. Quantitative PCR (qPCR) can detect low levels of P. jirovecii DNA but cannot differentiate between infection and colonization. Therefore a new and more accurate assay have to be used. 1,3 BD-glucan (BD-glucan) with a threshold value of 100 pg/ml can differentiate P. jirovecii infection from colonization.

Aim

The aim of this study is to evaluate the diagnostic accuracy of qPCR and BD-glucan assays in differentiating pneumocystis infection from colonization in immunocompromised patients with help of radiological pulmonary infiltrates.

Patients and methods

This study consisted of 75 immunocompromised patients (37 renal transplanted patients and 38 HIV patients) who were admitted for radiological pulmonary infiltrates and who presented a clinical picture suspecting PJP. They were investigated using microscopic staining of their respiratory samples (induced sputum or bronchoalveolar lavage).By applying both qPCR and serum BD-glucan assays we can differentiate between P. jirovecii infection from colonization.

Results

In this study, the first group of 25 patients were diagnosed as definite PJP, the second group of 20 patients were diagnosed as having pneumonia with P. jirovecii colonization, and a third group of 30 patients were diagnosed as having pneumonia without colonization. The number of copies of fungal DNA detected by qPCR were significantly higher in a definite PJP than in those with pneumonia accompanied with P. jirovecii colonization. Also BD-glucan assays were significantly higher in definite PJP by applying a threshold value of 100 pg/ml. The sensitivity and specificity of qPCR for differentiation of PJP infection from colonization were 100 and 64%, respectively, whereas the sensitivity and specificity of BD-glucan were 100 and 96%, respectively.

Conclusion

Both BD-glucan and qPCR assays had high diagnostic values in differentiating definite PJP from P. jirovecii colonization, and by applying qPCR with two cutoff values combined with serum BD-glucan using a threshold value of 100 pg/ml.

References

  1. Thomas CFJr, Limper AH. Pneumocystis pneumonia. N Engl J Med 2004;350:2487–2498.

    Article  CAS  Google Scholar 

  2. Neff RT, Jindal RM, Yoo DY, Hurst FP, Agodoa LY, Abbott KC. Analysis of USRDS:incidence and risk factors for Pneumocystis jiroveci pneumonia. Transplantation 2009;88:135–141.

    Article  Google Scholar 

  3. Azoulay E, Bergeron A, Chevret S, Bele N, Schlemmer B, Menotti J. Polymerase chain reaction for diagnosing Pneumocystis pneumonia in non-HIV immune-compromised patients with pulmonary infiltrates. Chest 2009;135:655–661.

    Article  CAS  Google Scholar 

  4. Fujisawa T, Suda T, Matsuda H, Inui N, Nakamura Y, Sato J, et al. Realtime PCR is more specific than conventional PCR for induced sputum diagnosis of Pneumocystis pneumonia in immunocompromised patients without HIV infection. Respirology 2009;14:203–209.

    Article  Google Scholar 

  5. Chumpitazi B, Flori P, Kern JB, Brenier-Pinchart MP, Hincky-Vitrat V, Brion JP, et al. Characteristics and clinical relevance of the quantitative touchdown major surface glycoprotein polymerase chain reaction in the diagnosis of Pneumocystis pneumonia. Med Mycol 2011;49:704–713.

    PubMed  Google Scholar 

  6. Damiani C, Gal SL, Costa CD, Virmaux M, Nevez G, Toteta A. Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1,3)-D-glucan for differential diagnosis of pneumocystis pneumonia and pneumocystis colonization. J Clin Microbiol 2013;51:3380–3388.

    Article  CAS  Google Scholar 

  7. De Boer MG, Gelinck LB, Van Zelst BD, Van de Sande WW, Willems LN, Van Dissel JT, et al. BD-glucan and s-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative patients:a prospective study. J Infect 2011;62:93–100.

    Article  Google Scholar 

  8. Matsumura Y, Ito Y, Iinuma Y, Yasuma K, Yamamoto M, Matsushima A. Quantitative real-time PCR and the (1,3)-BD-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization. Clin Microbiol Infect 2012;18:591–597.

    Article  CAS  Google Scholar 

  9. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock:2012. Crit Care Med 2013;41:580–637.

    Article  Google Scholar 

  10. DjukanovićR, Sterk PJ, Fahy JV,Hargreave FE. Standardized methodology of sputuminduction andprocessing. EurRespir J 2002;20(Suppl. 37):1s–2s.

  11. The British Thoracic Society Bronchoscopy Guideline Committee, A Sub-Committee of the Standards of Care Committee of the British Thoracic Society. British Thoracic Society guideline on the diagnostic flexible bronchoscopy. Thorax 2001; 56(Suppl I):1–21.

    Google Scholar 

  12. Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical significance of pneumocystis colonization. J Infect Dis 2008;197:10–17.

    Article  CAS  Google Scholar 

  13. Alanio A, Desoubeaux G, Sarfati C. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clin Microbiol Infect 2011;17:1531–1537.

    Article  CAS  Google Scholar 

  14. Fillaux J, Malvy S, Alvarez M. Accuracy of a routine real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia. J Microbiol Methods 2008;75:258–261.

    Article  CAS  Google Scholar 

  15. Botterel F, Cabaret O, Foulet F, Cordonnier C, Costa JM, Bretagne S. Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in broncho-alveolar lavage fluid from immune-compromised patients. J Clin Microbiol 2012;50:227–231.

    Article  CAS  Google Scholar 

  16. Muhlethaler K, Bogli-Stuber K, Wasmer S, Von Garneir C, Dumont P, Rauch A, et al. Quantitative PCR to diagnosis pneumocystis pneumonia in immunocompromised non-HIV patients. Eur Respir J 2012;39:971–978.

    Article  CAS  Google Scholar 

  17. Peterson JC, Cushion MT. Pneumocystis:not just pneumonia. Curr Opin Microbiol 2005;8:393–398.

    Article  CAS  Google Scholar 

  18. Desmet S, Van Wijngaerden E, Maertens J, Verhaegen J, Verbeken E, De MunterP, et al. Serum(1-3)-D-glucanasatool for diagnosis ofPneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. J Clin Microbiol 2009;47:3871–3874.

    Article  CAS  Google Scholar 

  19. Cuetara MS, Alhambra A, Chaves F, Moragues MD, Ponton J, del Palacio A. Use of a serum (1,3)-D-glucan assay for diagnosis and follow-up of Pneumocystis jirovecii pneumonia. Clin Infect Dis 2008;47:1364–1366.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chest Department, Faculty of Medicine, Zagazig University, Al-Sharkia Government, Faqus, Al Zeraaeen Building, 44511, Zagazig, Egypt

    Amal Abd Elazeem Sadon MD & Mohamed A. Saraya

Authors
  1. Amal Abd Elazeem Sadon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohamed A. Saraya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amal Abd Elazeem Sadon MD.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sadon, A.A.E., Saraya, M.A. Differentiation between pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Egypt J Bronchol 12, 467–472 (2018). https://doi.org/10.4103/ejb.ejb_105_17

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejb.ejb_105_17

Keywords